Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Patil

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
ACS Infectious Diseases|September 11, 2023
Antimalarial Dibenzannulated Medium-Ring Keto LactamsRongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Malaria Journal|January 4, 2020
An in vitro toolbox to accelerate anti-malarial drug discovery and developmentSusan A Charman, Alice Andreu, Helena Barker, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant DefensinSeow Theng Ong, Saumya Bajaj, Mark R Tanner, et al.
Science Translational Medicine|December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Journal of Medicinal Chemistry|December 23, 2024
Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria ChemopreventionZhe Nie, Roger Bonnert, Jet Tsien, et al.
Journal of Medicinal Chemistry|April 20, 2021
Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor SeriesMichael J Palmer, Xiaoyi Deng, Shawn Watts, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
ACS Infectious Diseases|September 11, 2023
Antimalarial Dibenzannulated Medium-Ring Keto LactamsRongguo Ren, Xiaofang Wang, Derek A Leas, et al.
Malaria Journal|January 4, 2020
An in vitro toolbox to accelerate anti-malarial drug discovery and developmentSusan A Charman, Alice Andreu, Helena Barker, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant DefensinSeow Theng Ong, Saumya Bajaj, Mark R Tanner, et al.
Science Translational Medicine|December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.
Journal of Medicinal Chemistry|December 23, 2024
Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria ChemopreventionZhe Nie, Roger Bonnert, Jet Tsien, et al.
Journal of Medicinal Chemistry|April 20, 2021
Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor SeriesMichael J Palmer, Xiaoyi Deng, Shawn Watts, et al.
Pageof 12